title: Sweet outcome for a rare inflammatory condition.
abstract: Sweet syndrome is a rare inflammatory condition that was first described by Douglas Sweet in 1964 as an acute febrile neutrophilic dermatosis. It can be associated with infections, inflammatory conditions,pregnancy, drugs, and malignancy. It is usually divided into three subtypes based on etiology: classical(idiopathic); malignancy-associated; and drug-induced. We describe a patient with classical Sweet syndrome who had a dramatic response to corticosteroids.Our patient met the major criteria for diagnosis (positive histopathology and an abrupt onset of a painful rash), along with 4 minor criteria (fever, preceding upper respiratory tract infection, dramatic response to steroids, and leukocytosis).
authors.affiliation: Resident in general surgery department, Najah National University Hospital, Aseera street, Nablus , West Bank-Palestine. salah.a.jalil@outloo.com.
authors.forename: Salah Abdel
authors.initials: SA
authors.lastname: Jalil
authors.forename: Owais
authors.initials: O
authors.lastname: Abdul-Kafi
authors.forename: James
authors.initials: J
authors.lastname: Smith
authors.forename: Ala' A Abdel
authors.initials: AA
authors.lastname: Jalil
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D016463:Sweet Syndrome / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone